The effect of oral evening primrose oil on menopausal hot flashes: a randomized clinical trial. 2013

Farah Farzaneh, and Setareh Fatehi, and Mohammad-Reza Sohrabi, and Kamyab Alizadeh
Gynecology Translational Research Center (GTRC), Imam Hossein Hospital, Shaheed Beheshti University of Medical Sciences, 16177-63141, Tehran, Iran, farahzaneh@yahoo.com.

OBJECTIVE Hot flashes are common experience for menopausal women, and for many, are severe enough to significantly compromise their overall sense of well being and quality of life. The aim of this study was to compare the efficacy of evening primrose with placebo in improvement of menopausal hot flashes. METHODS In a 6-week randomized clinical trial, a total of 56 menopausal women aged 45-59 years were participated in this study. The patients were asked for their hot flashes characteristics and responded to HFRDIS (hot flash related daily interference scale) questionnaire before and after the intervention. The participants were randomly assigned to take two capsules per day (totally 90 capsules for 6 weeks) of placebo or evening primrose (500 mg) for continuous 6 weeks. Then, the improvement in hot flashes was compared between two groups. RESULTS The percent of improvement in hot flash frequency, severity and duration were 39, 42 and 19 %, in evening primrose group compared with 32, 32 and 18 % in placebo group, respectively. Although all three characters of hot flash was ameliorated in evening primrose arm, only its severity was significantly better in this arm compared with placebo group (P < 0.05). All HFRDIS score were significantly improved in two groups, but the percentage of improvement in social activities, relations with others, and sexuality was significantly superior to placebo group (P < 0.05). CONCLUSIONS The application of oral evening primrose oil compared with placebo for controlling hot flashes may decrease more the intensity of attacks as well as ameliorating the HFRDIS score.

UI MeSH Term Description Entries
D007398 Interpersonal Relations The reciprocal interaction of two or more persons. Social Relationships,Husband-Wife Communication,Partner Communication,Communication, Husband-Wife,Communication, Partner,Husband Wife Communication,Husband-Wife Communications,Interpersonal Relation,Partner Communications,Relation, Interpersonal,Relationship, Social,Social Relationship
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012639 Seeds The encapsulated embryos of flowering plants. They are used as is or for animal feed because of the high content of concentrated nutrients like starches, proteins, and fats. Rapeseed, cottonseed, and sunflower seed are also produced for the oils (fats) they yield. Diaspores,Elaiosomes,Embryos, Plant,Plant Embryos,Plant Zygotes,Zygotes, Plant,Diaspore,Elaiosome,Embryo, Plant,Plant Embryo,Plant Zygote,Seed,Zygote, Plant
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity

Related Publications

Farah Farzaneh, and Setareh Fatehi, and Mohammad-Reza Sohrabi, and Kamyab Alizadeh
January 2018, Journal of education and health promotion,
Farah Farzaneh, and Setareh Fatehi, and Mohammad-Reza Sohrabi, and Kamyab Alizadeh
April 2021, Journal of menopausal medicine,
Farah Farzaneh, and Setareh Fatehi, and Mohammad-Reza Sohrabi, and Kamyab Alizadeh
February 1994, BMJ (Clinical research ed.),
Farah Farzaneh, and Setareh Fatehi, and Mohammad-Reza Sohrabi, and Kamyab Alizadeh
June 2013, Journal of caring sciences,
Farah Farzaneh, and Setareh Fatehi, and Mohammad-Reza Sohrabi, and Kamyab Alizadeh
August 2021, Journal of menopausal medicine,
Farah Farzaneh, and Setareh Fatehi, and Mohammad-Reza Sohrabi, and Kamyab Alizadeh
January 2009, Menopause (New York, N.Y.),
Farah Farzaneh, and Setareh Fatehi, and Mohammad-Reza Sohrabi, and Kamyab Alizadeh
January 2023, Iranian journal of nursing and midwifery research,
Farah Farzaneh, and Setareh Fatehi, and Mohammad-Reza Sohrabi, and Kamyab Alizadeh
January 2020, BioMedicine,
Farah Farzaneh, and Setareh Fatehi, and Mohammad-Reza Sohrabi, and Kamyab Alizadeh
March 2020, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
Farah Farzaneh, and Setareh Fatehi, and Mohammad-Reza Sohrabi, and Kamyab Alizadeh
February 2016, Annals of internal medicine,
Copied contents to your clipboard!